CannaPowder, Inc. (CAPD) financial statements (2022 and earlier)

Company profile

Business Address 20 RAOUL WALLENBERG ST.,
TEL AVIV,, 6971916
State of Incorp. UT
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20569426932714721
Cash and cash equivalents20569426707606721
Short-term investments   224108 
Prepaid expense391745191315
Deposits current assets38     
Total current assets:28286471951727736
Noncurrent Assets
TOTAL ASSETS:28286471951727736
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:116 14525 
Interest and dividends payable6     
Other undisclosed accounts payable and accrued liabilities110 14525 
Due to related parties550     
Other undisclosed current liabilities  (11)   
Total current liabilities:666 3525 
Noncurrent Liabilities
Other undisclosed noncurrent liabilities  14   
Total noncurrent liabilities:  14   
Total liabilities:666 17525 
Stockholders' equity
Stockholders' equity attributable to parent, including:(384)86454946702736
Common stock000000
Additional paid in capital6,0995,9445,8335,1024,4721,261
Accumulated other comprehensive income (loss)(33)5(1)(55)(174)(5)
Accumulated deficit(6,341)(5,767)(5,303)(4,052)(3,573)(499)
Other undisclosed stockholders' equity attributable to parent(109)(96)(75)(48)(23)(22)
Total stockholders' equity:(384)86454946702736
TOTAL LIABILITIES AND EQUITY:28286471951727736

Income statement (P&L) ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
Operating expenses(581)(485)(1,250)(489)(3,091)(103)
Operating loss:(581)(485)(1,250)(489)(3,091)(103)
Nonoperating income (expense)(5)(486)(28)(3)19 
Foreign currency transaction loss, before tax   (3)  
Other undisclosed loss from continuing operations before equity method investments, income taxes(6)     
Loss from continuing operations before equity method investments, income taxes:(592)(971)(1,277)(492)(3,072)(103)
Other undisclosed income from continuing operations before income taxes 485    
Loss before gain (loss) on sale of properties:(592)(486)(1,277)(492)(3,072)(103)
Other undisclosed net income (loss)6  3(19) 
Net loss:(586)(486)(1,277)(489)(3,091)(103)
Net income attributable to noncontrolling interest1221    
Other undisclosed net income attributable to parent  2711167
Net loss available to common stockholders, diluted:(574)(464)(1,251)(479)(3,075)(96)

Comprehensive Income ($ in thousands)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
Net loss:(586)(486)(1,277)(489)(3,091)(103)
Other undisclosed comprehensive income (loss)  4119(191)6
Comprehensive loss:(586)(486)(1,273)(371)(3,282)(97)
Comprehensive income, net of tax, attributable to noncontrolling interest12212711167
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(37)6    
Comprehensive loss, net of tax, attributable to parent:(611)(458)(1,247)(360)(3,266)(90)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: